These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 2619152)
1. Ocular toxicity of tamoxifen. Gerner EW Ann Ophthalmol; 1989 Nov; 21(11):420-3. PubMed ID: 2619152 [TBL] [Abstract][Full Text] [Related]
2. [Birdshot chorioretinopathy associated with tamoxifen retinal toxicity]. Sommer S; Badet JC; Zaoui M; Naoun-Hubert I; Rozot P J Fr Ophtalmol; 2000 May; 23(5):494-7. PubMed ID: 10844311 [TBL] [Abstract][Full Text] [Related]
3. Crystalline maculopathy: a rare complication of tamoxifen therapy. Srikantia N; Mukesh S; Krishnaswamy M J Cancer Res Ther; 2010; 6(3):313-5. PubMed ID: 21119261 [TBL] [Abstract][Full Text] [Related]
4. Tamoxifen retinopathy. Kaiser-Kupfer MI; Lippman ME Cancer Treat Rep; 1978 Mar; 62(3):315-20. PubMed ID: 647693 [TBL] [Abstract][Full Text] [Related]
5. Ocular toxicity in low-dose tamoxifen: a prospective study. Noureddin BN; Seoud M; Bashshur Z; Salem Z; Shamseddin A; Khalil A Eye (Lond); 1999 Dec; 13 ( Pt 6)():729-33. PubMed ID: 10707134 [TBL] [Abstract][Full Text] [Related]
6. Tamoxifen retinopathy. A case report. Costa RH; Dhooge MR; Van Wing F; De Rouck AF Bull Soc Belge Ophtalmol; 1990; 238():161-8. PubMed ID: 2131119 [TBL] [Abstract][Full Text] [Related]
7. Retinal changes associated with tamoxifen treatment for breast cancer. Tang R; Shields J; Schiffman J; Li H; Locher D; Hampton J; Prager T; Pardo G Eye (Lond); 1997; 11 ( Pt 3)():295-7. PubMed ID: 9373465 [TBL] [Abstract][Full Text] [Related]
8. Tamoxifen and ocular toxicity. Ah-Song R; Sasco AJ Cancer Detect Prev; 1997; 21(6):522-31. PubMed ID: 9398992 [TBL] [Abstract][Full Text] [Related]
10. Ocular toxicity during adjuvant chemoendocrine therapy for early breast cancer: results from International Breast Cancer Study Group trials. Gianni L; Panzini I; Li S; Gelber RD; Collins J; Holmberg SB; Crivellari D; Castiglione-Gertsch M; Goldhirsch A; Coates AS; Ravaioli A; Cancer; 2006 Feb; 106(3):505-13. PubMed ID: 16369994 [TBL] [Abstract][Full Text] [Related]
11. Peripheral retinopathy and maculopathy in high-dose tamoxifen therapy. Bourla DH; Sarraf D; Schwartz SD Am J Ophthalmol; 2007 Jul; 144(1):126-8. PubMed ID: 17601434 [TBL] [Abstract][Full Text] [Related]
13. Multifocal electroretinography, color discrimination and ocular toxicity in tamoxifen use. Salomão SR; Watanabe SE; Berezovsky A; Motono M Curr Eye Res; 2007 Apr; 32(4):345-52. PubMed ID: 17453956 [TBL] [Abstract][Full Text] [Related]
14. [Ophthalmologic complications of low-dose tamoxifen in the treatment of breast carcinoma]. Ned Tijdschr Geneeskd; 1989 Apr; 133(17):903-4. PubMed ID: 2725755 [No Abstract] [Full Text] [Related]
15. Screening for ocular toxicity in asymptomatic patients treated with tamoxifen. Heier JS; Dragoo RA; Enzenauer RW; Waterhouse WJ Am J Ophthalmol; 1994 Jun; 117(6):772-5. PubMed ID: 7880223 [TBL] [Abstract][Full Text] [Related]
16. Ocular assessment of patients treated with tamoxifen. Beck M; Mills PV Cancer Treat Rep; 1979; 63(11-12):1833-4. PubMed ID: 526917 [TBL] [Abstract][Full Text] [Related]
17. Tamoxifen retinopathy: does it really exist? Lazzaroni F; Scorolli L; Pizzoleo CF; Savini G; De Nigris A; Giosa F; Meduri RA Graefes Arch Clin Exp Ophthalmol; 1998 Sep; 236(9):669-73. PubMed ID: 9782427 [TBL] [Abstract][Full Text] [Related]
18. Megestrol acetate v tamoxifen in advanced breast cancer in postmenopausal patients. Morgan LR Semin Oncol; 1985 Mar; 12(1 Suppl 1):43-7. PubMed ID: 3975652 [TBL] [Abstract][Full Text] [Related]
19. Tamoxifen retinopathy: a rare but serious complication. Bentley CR; Davies G; Aclimandos WA BMJ; 1992 Feb; 304(6825):495-6. PubMed ID: 1312376 [No Abstract] [Full Text] [Related]
20. Retinal changes associated with tamoxifen treatment for breast cancer. Murray DC; Gibson JM Eye (Lond); 1998; 12 ( Pt 3a)():485-6. PubMed ID: 9775258 [No Abstract] [Full Text] [Related] [Next] [New Search]